Voyager Therapeutics VYGR
NASDAQ VYGR
$2.02 -0.17 (-7.76%)
As of: Oct 21, 2026 · 3:40 PM EDT

Voyager Therapeutics (VYGR) Construction in Progress (2016)

Updated

Voyager Therapeutics' Construction in Progress was $3 million in Q4 2016.

Analysis

Voyager Therapeutics (VYGR) Construction in Progress (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn -
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn -
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn -
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn -
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn -
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn -
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn -
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn -
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn -
10 Voyager Therapeutics 122.61 Mn -540.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 3.00 Mn
API Access

Voyager Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=VYGR&period=max&api_key=YOUR_API_KEY